Laparoscopic splenic hilum lymph node dissection for advanced proximal gastric cancer: A modified approach for pancreas- and spleen-preserving total gastrectomy

Table 1 Clinicopathological characteristics of patients

Patient No.	Gender	Age (yr)	BMI (kg/mkg/m2)	Tumor location	Tumor size (cm)	Tumor depth1	TNM stage1	No. of retrieved LN2	No. of metastatic LN2	No. of retrieved splenic hilum LN2	No. of metastatic splenic hilum LNc
1	Male	60	19.1	U	5.0	T4a	IIIC	21	7	3	0
2	Male	73	24.8	U	6.0	T4a	IIIB	18	5	4	0
3	Male	61	20.6	U	8.5	T4a	IIIA	34	2	8	0
4	Male	62	20.2	U	7.0	T3	IIA	39	0	4	0
5	Male	59	20.8	U	4.5	T4a	IIB	16	0	3	0
6	Female	54	20.4	M	5.0	T4a	IIIA	20	1	5	0
7	Female	57	24.0	U	5.0	T4a	IIIA	20	1	7	0
8	Male	57	19.1	U	8.0	T4a	IIIC	28	21	6	3
9	Male	61	25.6	U	3.5	T4a	IIIA	16	2	4	0
10	Male	63	21.1	M	2.9	T4a	IIB	24	0	5	0
11	Female	75	21.8	U	5.5	T4a	IIIB	19	3	2	0
12	Male	45	20.6	M	4.0	T4a	IIB	35	0	6	0

¹“Tumor depth” and “Tumor node metastasis (TNM) stage” were in accordance with the AJCC cancer staging manual-7^th edition;

²Lymph nodes (LN). BMI: Body mass index.